ArticlePloS one2026
Upregulation of angiotensin-(1-7) formation in human podocytes - enzyme activity assay upon fluid flow shear stress.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The renin-angiotensin system is known for its role in renal physiology by regulating renal hemodynamics and natriuresis. Overactivation of this system exerts pathological effects in the kidney, primarily mediated by its main effector peptide angiotensin II. Deleterious angiotensin II-mediated effects are counter-regulated at least partly by the biologically active renin-angiotensin system component angiotensin-(1-7). The processing of angiotensin II to angiotensin-(1-7) by prolylcarboxypeptidase, angiotensin converting enzyme 2, and prolyl endopeptidase is cell- and species-specific, with limited knowledge regarding its conversion in human podocytes under conditions of glomerular hyperfiltration. Since hyperfiltration plays a critical mechanistic role in albuminuria progression and chronic kidney disease, understanding the mechanisms underlying podocyte damage due to glomerular hyperfiltration is essential. Therefore, we investigated the conversion of angiotensin II to angiotensin-(1-7) in cultured human podocytes exposed to fluid flow shear stress and subsequently incubated with spiked angiotensin II. Mass spectrometry of cell lysates and supernatants was performed to evaluate the formation of angiotensin-(1-7). Contribution of the respective enzymes to angiotensin-(1-7) formation was assessed using selective inhibitors of prolylcarboxypeptidase, angiotensin converting enzyme 2, and prolyl endopeptidase. We detected increased angiotensin-(1-7) formation upon fluid flow shear stress in podocyte lysates, which was mainly dependent on prolylcarboxypeptidase activity. Our study contributes to a deeper understanding of the intraglomerular processing of angiotensin II towards the alternative renin-angiotensin system and its modulation upon fluid flow shear stress.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.